Is IP-10 a Better Biomarker for Active and Latent Tuberculosis in Children Than IFNgamma?

PLoS One. 2008;3(12):e3901. doi: 10.1371/journal.pone.0003901. Epub 2008 Dec 9.

Abstract

Background: The blood based interferon-gamma release assays (IGRA) for the diagnosis of tuberculosis do not discriminate between active TB disease and latent TB infection (LTBI). The search for distinguishing biomarkers therefore continues, as the accurate diagnosis of tuberculosis is particularly challenging in children. IFN-gamma-inducible protein 10 (IP-10/CXCL10) has recently been evaluated as a marker for active TB in adults with promising results.

Aim: To investigate this new biomarker for active TB and LTBI in paediatrics.

Method: We measured IP-10 levels using ELISA in supernatants of whole blood samples stimulated with TB-specific-antigens and negative control antigen.

Results: IP-10 is produced in high levels following mycobacterial antigen stimulation in active TB (n = 17) and LTBI (n = 16) compared to controls (n = 16) and to IFN-gamma. The baseline levels of IP-10 are increased in active TB and in LTBI, but there is no significant difference of stimulated levels of IP-10 between active TB and LTBI.

Conclusions: IP-10 is a biomarker for tuberculosis in children. However like IFNgamma, IP-10 also does not distinguish between active TB and LTBI.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antigens, Bacterial / immunology
  • Biomarkers / blood
  • Case-Control Studies
  • Chemokine CXCL10 / blood*
  • Child
  • Child, Preschool
  • Diagnosis, Differential
  • Humans
  • Infant
  • Infant, Newborn
  • Interferon-gamma / blood*
  • Tuberculosis / blood*
  • Tuberculosis / diagnosis*
  • Tuberculosis / immunology

Substances

  • Antigens, Bacterial
  • Biomarkers
  • CXCL10 protein, human
  • Chemokine CXCL10
  • Interferon-gamma